Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 6/20 | 0.48 |
| ▸ | MAOB | P27338 | 6/20 | 0.48 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.43 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ACSL1 | P33121 | 2/20 | 0.41 |
| ▸ | ACSL6 | Q9UKU0 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245876 | 0.89 | KDM4E (0.53) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL30845908 | 0.88 | PTPN7 (0.50) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL1505814 | 0.86 | MAPT (0.67) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL1469810 | 0.86 | KDM4E (0.62) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL10958084 | 0.85 | KDM4E (0.58) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL2293712 | 0.85 | KDM4E (0.58) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL12795345 | 0.84 | MAOA (0.55) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL24949252 | 0.84 | KDM4E (0.57) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL10932212 | 0.84 | ACSL1 (0.58) | KDM4EALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL14209211 | 0.84 | KDM4E (0.57) | KDM4EALDH1A1NPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230256753-A1 | INK JET PRINTING METHOD, INK JET PRINTING APPARATUS, METHOD OF PRODUCING POROUS BODY, AND APPARATUS FOR PRODUCING POROUS BODY | CANON KABUSHIKI KAISHA (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20160195808-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | TOYO GOSEI CO LTD (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160147144-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | TOYO GOSEI CO., LTD (JP) | 2016-05-26 | — | — | US | disclosed |
| WO-2015022779-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | TOYO GOSEI CO., LTD. (JP) | 2015-02-19 | — | — | WO | disclosed |
| WO-2014208102-A1 | Reagent for Enhancing Generation of Chemical Species | TOYO GOSEI CO., LTD. (JP) | 2014-12-31 | — | — | WO | disclosed |
| US-8158746-B2 | Active energy ray curable liquid composition and liquid cartridge | CANON KABUSHIKI KAISHA (JP) | 2012-04-17 | — | — | US | disclosed |
| US-8124791-B2 | Active energy ray curable liquid composition and liquid cartridge | CANON KABUSHIKI KAISHA (JP) | 2012-02-28 | — | — | US | disclosed |
| US-7976148-B2 | Active energy ray curable aqueous ink composition, and inkjet recording method, ink cartridge, recording unit, and inkjet recording apparatus using the same | CANON KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20100324163-A1 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE | CANON KABUSHIKI KAISHA (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-2246330-A1 | New photoinitiators | Siegwerk Benelux SA (BE) | 2010-11-03 | — | — | EP | disclosed |
| US-20100094024-A1 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE | CANON KABUSHIKI KAISHA (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20090286001-A1 | ACTIVE-ENERGY RADIATION-POLYMERIZABLE SUBSTANCE, ACTIVE-ENERGY RADIATION-CURABLE LIQUID COMPOSITION, ACTIVE-ENERGY RADIATION-CURABLE INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-11-19 | — | — | US | disclosed |
| US-6245922-B1 | PREPARED BY REACTING AN ELECTROPHILIC 2-ALKENYL AZALACTONE WITH A NUCLEOPHILIC AROMATIC KETONE; CAN BE COPOLYMERIZED WITH ACRYLIC MONOMERS AND PHOTOACTIVATED BY ACTINIC RADIATION TO CROSSLINK THE POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2001-06-12 | — | — | US | disclosed |
| EP-0837844-B1 | ACRYLAMIDE DERIVATIVES AS CHROMOPHORIC PHOTOCROSSLINKING COMPOUND | MINNESOTA MINING & MFG (US) | 2000-04-05 | — | — | EP | disclosed |
| EP-0837844-A1 | ACRYLAMIDE DERIVATIVES AS CHROMOPHORIC PHOTOCROSSLINKING COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-04-29 | — | — | EP | disclosed |
| WO-1997005101-A1 | ACRYLAMIDE DERIVATIVES AS CHROMOPHORIC PHOTOCROSSLINKING COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286001-A1 | ACTIVE-ENERGY RADIATION-POLYMERIZABLE SUBSTANCE, ACTIVE-ENERGY RADIATION-CURABLE LIQUID COMPOSITION, ACTIVE-ENERGY RADIATION-CURABLE INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK JET RECORDING APPARATUS | DACH1, MMP1, IDUA | KDM4E 2356/4885ALDH1A1 591/4885NPC1 4711/4885 |
| US-20100094024-A1 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE | C9, MLX, CHRM1 | KDM4E 2960/4885ALDH1A1 3555/4885NPC1 3731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.